<?xml version="1.0" encoding="UTF-8"?>
<results title="testTrace">
 <result pre="include leveraging harm reduction tools and improving integrated prevention and" exact="treatment" post="services for the infectious diseases and substance use disorder"/>
 <result pre="and addiction specialists, including increasing training in substance use disorder" exact="treatment" post="among infectious diseases and addiction specialists, we can decrease"/>
 <result pre="these overlapping epidemics. injection drug use opioid epidemic medications for" exact="treatment" post="of opioid use disorder Funding National Institute on Drug"/>
 <result pre="10–12]. In addition to HIV, both acute HCV and HBV" exact="infection" post="incidence has mirrored the rise in injection opioids [5,"/>
 <result pre="recommend expanding Medicaid, expanding access to harm reduction services, improving" exact="treatment" post="and surveillance to enhance the continuum of care, and"/>
 <result pre="WHY DOES IT MATTER TO INFECTIOUS DISEASES CLINICIANS? Medications for" exact="treatment" post="of opioid use disorder (MOUDs, which is now the"/>
 <result pre="people living with HIV, the gold standard of care in" exact="treatment" post="of HIV that is associated with reduced mortality and"/>
 <result pre="the Drug Enforcement Agency in the case of buprenorphine or" exact="treatment" post="in a federally certified opioid treatment program in the"/>
 <result pre="case of buprenorphine or treatment in a federally certified opioid" exact="treatment" post="program in the case of methadone. Unfortunately, many clinical"/>
 <result pre="physicians have waivers to prescribe buprenorphine and most substance use" exact="treatment" post="programs do not have opioid treatment programs, which makes"/>
 <result pre="and most substance use treatment programs do not have opioid" exact="treatment" post="programs, which makes methadone treatment challenging to obtain [18]."/>
 <result pre="programs do not have opioid treatment programs, which makes methadone" exact="treatment" post="challenging to obtain [18]. Therefore, the prevailing care for"/>
 <result pre="relapse to opioid use after failure to connect with OUD" exact="treatment" post="referrals. Such inadequate care results in prolonged hospitalizations due"/>
 <result pre="leave the hospital, readmissions after OUD relapse, and, if concomitant" exact="infection" post="is present, lack of antibiotic adherence and reinfection. Ultimately,"/>
 <result pre="predict and respond to emerging epidemics. 11. Integrate MOUD and" exact="counseling" post="services during incarceration. 12. Integrate screening for OUD and treatment"/>
 <result pre="epidemics. 11. Integrate MOUD and counseling services during incarceration. 12. Integrate" exact="screening" post="for OUD and treatment with MOUD into jails and"/>
 <result pre="and counseling services during incarceration. 12. Integrate screening for OUD and" exact="treatment" post="with MOUD into jails and prisons. 13. Expand access to"/>
 <result pre="human immunodeficiency virus; IDU, injection drug use; MOUD, medication for" exact="treatment" post="of opioid use disorder; OUD, opioid use disorder; SSPs,"/>
 <result pre="including provisions that improved Medicaid and Medicare coverage of SUD" exact="treatment" post="and services, and that increased the patient cap for"/>
 <result pre="repayment over 6 years for providers working in substance use" exact="treatment" post="facilities [20]. Both programs depend on Congress to appropriate"/>
 <result pre="provide funding to states to support comprehensive prevention, care, and" exact="treatment" post="programs [23]; and the Mainstreaming Addiction Treatment Act that"/>
 <result pre="harm reduction services, including access to MOUD and infectious diseases" exact="treatment" post="services in order to decrease HCV, HIV, IDU-related infections,"/>
 <result pre="space without stigma for individuals with SUDs to also receive" exact="counseling" post="regarding safe sexual practice, safe injection practice, and provision"/>
 <result pre="HIV preexposure prophylaxis (PrEP) and contraception. SSPs that also provide" exact="treatment" post="for OUD can facilitate linkage to care for effective"/>
 <result pre="outcomes for people with HIV [43]. As a next step," exact="treatment" post="programs that integrate substance use care and treatment for"/>
 <result pre="next step, treatment programs that integrate substance use care and" exact="treatment" post="for infectious complications in order to improve outcomes are"/>
 <result pre="HIV, HCV) can be cost-effective and is associated with improved" exact="infection" post="and SUD outcomes [44]. Previous studies have shown that"/>
 <result pre="However, significant gaps remain in understanding the role substance use" exact="treatment" post="plays in caring for people with other IDU-related infections,"/>
 <result pre="One innovative care model combined outpatient parenteral therapy with buprenorphine" exact="treatment" post="and showed similar clinical and drug use outcomes to"/>
 <result pre="[48]. Studies are needed to evaluate novel approaches to antimicrobial" exact="treatment" post="for IDU-associated infections such as the role of long-acting"/>
 <result pre="some physicians from integrating buprenorphine into their practice for the" exact="treatment" post="of OUD [49]. Warmlines, such as the one run"/>
 <result pre="locator https://www.samhsa.gov/medication-assisted-treatment/practitioner-program-data/treatment-practitioner-locator Buprenorphine waiver and training resources https://www.samhsa.gov/medication-assisted-treatment/training-materials-resources/apply-for-practitioner-waiver Behavioral health" exact="treatment" post="services locator https://findtreatment.samhsa.gov/ Clinical consultation center—substance use management warmline"/>
 <result pre="technical assistance consortium https://opioidresponsenetwork.org/ Support for hospital opioid use disorder" exact="treatment" post="https://www.projectshout.org In addition, a reorganization of the buprenorphine prescribing"/>
 <result pre="increase medication uptake and improve outcomes by increasing access to" exact="treatment" post="where people reside. In addition, multidisciplinary team meetings, including"/>
 <result pre="women [52] and has been successfully integrated into most prenatal" exact="screening" post="paradigms, allowing for perinatal management that decreases the risk"/>
 <result pre="risk of infant infection. In September 2006, the CDC recommended" exact="screening" post="all sexually active persons 13–65 years old for HIV"/>
 <result pre="Services Task Force issued a draft recommendation for universal HCV" exact="screening" post="[53]. Given that overall incidence of HCV is increasing"/>
 <result pre="education and increased resources are needed to ensure universal HCV" exact="testing" post="is performed, particularly among women of child-bearing age and"/>
 <result pre="of child-bearing age and in prenatal care to prevent infant" exact="infection" post="[55–57]. Persons experiencing homelessness and unstable housing are similarly"/>
 <result pre="with SUD. This is, in part, due to the high" exact="prevalence" post="of concomitant untreated mental illness and SUD among these"/>
 <result pre="population. In addition to ensuring persons who experience homelessness receive" exact="treatment" post="of their infectious diseases and SUD through low-barrier and"/>
 <result pre="majority of federal funding has been directed towards opioid overdose" exact="treatment" post="and HIV resultant from IDU, but not toward the"/>
 <result pre="resultant from IDU, but not toward the bacterial and fungal" exact="infection" post="complications, partly due to lack of integrated surveillance systems"/>
 <result pre="population (CJIP) have OUD or SUD, with a 10-fold higher" exact="prevalence" post="than found in the general adult population [62]. As"/>
 <result pre="general adult population [62]. As such, employing and enforcing evidence-based" exact="treatment" post="guidelines that address the overlap of SUD and infectious"/>
 <result pre="new entrants for SUD and IDU-related infections, integrating MOUD and" exact="counseling" post="services during incarceration, providing both appropriate medical care during"/>
 <result pre="HIV, and HBV/HCV-induced liver disease [66–68]. Additionally, overall infectious disease" exact="testing" post="rates and rates of vaccination against HAV and HBV"/>
 <result pre="are low [69, 70]. Integration of infectious disease management with" exact="treatment" post="for OUD in CJIP is an endorsed strategy for"/>
 <result pre="Despite the evidence, however, few incarcerated settings offer MOUD. SUD" exact="screening" post="in jails and prisons with linkage to substance use"/>
 <result pre="screening in jails and prisons with linkage to substance use" exact="treatment" post="also decreases postrelease mortality [72, 73] and increases postrelease"/>
 <result pre="increases postrelease HIV viral suppression [16, 17]. Clearly, prevention and" exact="treatment" post="for OUD and associated infections in this population can"/>
 <result pre="opportunity to engage a vulnerable population. Screening for OUD and" exact="treatment" post="with MOUD need to be integrated into jails and"/>
 <result pre="improve substance use and infectious diseases outcomes. In addition to" exact="testing" post="and treatment, access to harm reduction tools to prevent"/>
 <result pre="testing and treatment, access to harm reduction tools to prevent" exact="infection" post="needs to be prioritized in the CJIP. Harm reduction"/>
 <result pre="be implemented in jails, effectively containing outbreaks [77]. Substance use" exact="treatment" post="coupled with uninterrupted health insurance is needed to improve"/>
 <result pre="jail and prison. As a case study, expansion of HCV" exact="treatment" post="during incarceration is feasible, cost-effective, and the best option"/>
 <result pre="to move closer to national HCV elimination [78, 79]. HCV" exact="diagnosis" post="in jails with linkage postrelease is a feasible alternative"/>
 <result pre="jails with linkage postrelease is a feasible alternative if HCV" exact="treatment" post="costs are deemed prohibitive [80]. A major barrier in"/>
 <result pre="Centers for Disease Control and Prevention (CDC)Community outbreak of HIV" exact="infection" post="linked to injection drug use of oxymorphone–Indiana, 2015. MMWR"/>
 <result pre="5.ZibbellJE, AsherAK, PatelRC, et al.Increases in acute hepatitis C virus" exact="infection" post="related to a growing opioid epidemic and associated injection"/>
 <result pre="68:253–4.30870405 11.GoldenMR, LechtenbergR, GlickSN, et al.Outbreak of human immunodeficiency virus" exact="infection" post="among heterosexual persons who are living homeless and inject"/>
 <result pre="68:344–9.30998671 12.EvansME, LabudaSM, HoganV, et al.Notes from the field: HIV" exact="infection" post="investigation in a rural area—West Virginia, 2017. MMWR Morb"/>
 <result pre="and Human Services, 2018. 15.GowingL, FarrellMF, BornemannR, SullivanLE, AliROral substitution" exact="treatment" post="of injecting opioid users for prevention of HIV infection."/>
 <result pre="Acquir Immune Defic Syndr2018; 78:43–53.29373393 18.collab: Congressional Research Service. Opioid" exact="treatment" post="programs and related federal regulations. Washington, DC: United States"/>
 <result pre="of Sciences, Engineering, and Medicine, 2018. 27.SpringerSA, KorthuisPT, Del RioCintegrating" exact="treatment" post="at the intersection of opioid use disorder and infectious"/>
 <result pre="Drug Policy2019; 67:9–18.30802842 41.MeinhoferA, WitmanAEThe role of health insurance on" exact="treatment" post="for opioid use disorders: evidence from the Affordable Care"/>
 <result pre="Prev Med2018; 54:S208–S14.29779544 50.TalalAH, AndrewsP, McleodA, et al.Integrated, co-located, telemedicine-based" exact="treatment" post="approaches for hepatitis C virus management in opioid use"/>
 <result pre="Preventive Services Task Force. Draft recommendation statement hepatitis C virus" exact="infection" post="in adolescents and adults: screening. Rockville, MD: USPSTF, 2019."/>
 <result pre="54.ZibbellJE, AsherAK, PatelRC, et al.Increases in acute hepatitis C virus" exact="infection" post="related to a growing opioid epidemic and associated injection"/>
 <result pre="Health2018; 108:175–81.29267061 55.LyKN, JilesRB, TeshaleEH, FosterMA, PesanoRL, HolmbergSDHepatitis C virus" exact="infection" post="among reproductive-aged women and children in the United States,"/>
 <result pre="Intern Med2013; 158:109–13.23437438 57.BellR, WolfeI, CoxD, ThakaraK, LucasL, CraigAHepatitis C" exact="screening" post="in mothers and infants exposed to opioids. Hosp Pediatr2019;"/>
 <result pre="BeiserM, LeónC, GaetaJM, O’ConnellJJ, LinasBPExperience and outcomes of hepatitis C" exact="treatment" post="in a cohort of homeless and marginally housed adults."/>
 <result pre="JAMA Intern Med2017; 177:880–2.28395004 60.BeiserME, SmithK, IngemiM, MulliganE, BaggettTPHepatitis C" exact="treatment" post="outcomes among homeless-experienced individuals at a community health centre"/>
 <result pre="of Justice, 2017. 63.HennesseyKA, KimAA, GriffinV, CollinsNT, WeinbaumCM, SabinKPrevalence of" exact="infection" post="with hepatitis B and C viruses and co-infection with"/>
 <result pre="Brinkley-RubinsteinL, et al.Postincarceration fatal overdoses after implementing medications for addiction" exact="treatment" post="in a statewide correctional system. JAMA Psychiatry2018; 75:405–7.29450443 73.DegenhardtL,"/>
 <result pre="TasilloA, VellozziC, et al.Cost-effectiveness and budgetary impact of HCV testing," exact="treatment" post="and linkage to care in U.S. prisons [published online"/>
 <result pre="10.1093/cid/ciz383. 79.HeT, LiK, RobertsMS, et al.Prevention of hepatitis C by" exact="screening" post="and treatment in U.S. prisons. Ann Intern Med2016; 164:84–92.26595252"/>
 <result pre="LiK, RobertsMS, et al.Prevention of hepatitis C by screening and" exact="treatment" post="in U.S. prisons. Ann Intern Med2016; 164:84–92.26595252 80.NguyenJT, RichJD,"/>
</results>
